Essais liés2clinical trials
VilleSafedlocalisation
PaysIsraellocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT01918501

Ouvrir le site du centre

Essais cliniques associés

2
MoléculeIndication / populationPhaseNCTTitreStatut
Blood testing SEP Non applicable NCT01918501 Testing Mitochondria Activity and Blood Lipid Content of Multiple Sclerosis Patients UNKNOWN
Ponesimod SEP Phase 3 NCT03232073 Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple Sclerosis COMPLETED